As of 2025-10-19, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 65.98 USD. This relative valuation is based on P/E multiples. With the latest stock price at 140.09 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -52.9%.
The range of the Relative Valuation is 52.12 - 87.70 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 16.5x | 15.8x |
| Forward P/E multiples | 16.4x - 21.7x | 19.0x |
| Fair Price | 52.12 - 87.70 | 65.98 |
| Upside | -62.8% - -37.4% | -52.9% |
| Date | P/E |
| 2025-10-17 | 39.89 |
| 2025-10-16 | 39.16 |
| 2025-10-15 | 39.22 |
| 2025-10-14 | 39.08 |
| 2025-10-13 | 39.11 |
| 2025-10-10 | 38.91 |
| 2025-10-09 | 39.43 |
| 2025-10-08 | 39.60 |
| 2025-10-07 | 39.01 |
| 2025-10-06 | 39.70 |
| 2025-10-03 | 39.02 |
| 2025-10-02 | 38.94 |
| 2025-10-01 | 39.01 |
| 2025-09-30 | 39.97 |
| 2025-09-29 | 39.94 |
| 2025-09-26 | 40.44 |
| 2025-09-25 | 40.12 |
| 2025-09-24 | 41.76 |
| 2025-09-23 | 41.69 |
| 2025-09-22 | 41.75 |
| 2025-09-19 | 41.35 |
| 2025-09-18 | 41.48 |
| 2025-09-17 | 40.64 |
| 2025-09-16 | 40.12 |
| 2025-09-15 | 39.99 |
| 2025-09-12 | 40.40 |
| 2025-09-11 | 40.89 |
| 2025-09-10 | 40.22 |
| 2025-09-09 | 41.05 |
| 2025-09-08 | 40.95 |
| 2025-09-05 | 41.03 |
| 2025-09-04 | 39.98 |
| 2025-09-03 | 38.76 |
| 2025-09-02 | 40.41 |
| 2025-08-29 | 39.75 |
| 2025-08-28 | 39.56 |
| 2025-08-27 | 39.33 |
| 2025-08-26 | 38.97 |
| 2025-08-25 | 38.15 |
| 2025-08-22 | 38.56 |
| 2025-08-21 | 38.52 |
| 2025-08-20 | 37.94 |
| 2025-08-19 | 37.82 |
| 2025-08-18 | 37.91 |
| 2025-08-15 | 37.84 |
| 2025-08-14 | 37.39 |
| 2025-08-13 | 37.48 |
| 2025-08-12 | 36.70 |
| 2025-08-11 | 35.30 |
| 2025-08-08 | 35.60 |